Please ensure Javascript is enabled for purposes of website accessibility

Invesco DWA Healthcare Momentum ETF (PTH) - Wall Street’s Best Digest Daily Alert - 4/13/21

The top five holdings in this healthcare fund are: Pacific Biosciences of California Inc (PACB, 7.19% of assets), Danaher Corp (DHR, 4.72%), TG Therapeutics Inc (TGTX, 4.58%(, Fulgent Genetics Inc (FLGT, 4.10%), and Repligen Corp (RGEN, 3.89%).

The top five holdings in this healthcare fund are: Pacific Biosciences of California Inc (PACB, 7.19% of assets), Danaher Corp (DHR, 4.72%), TG Therapeutics Inc (TGTX, 4.58%), Fulgent Genetics Inc (FLGT, 4.10%), and Repligen Corp (RGEN, 3.89%).

Invesco DWA Healthcare Momentum ETF (PTH)
From Sound Advice

Invesco DWA Healthcare Momentum Portfolio ETF has been a stellar performer in recent years and has consistently had Morningstar’s highest ratings of 4 and 5 stars over various periods during the last 10 years.

The secret to the strong performance of PTH is its focus on relative strength—the measurement of a security’s performance in a given sector over time as compared to the performance of all other securities in that sector.

PTH bases its holdings on the Dorsey Wright Healthcare Technical Leaders Index which is designed to identify companies that are showing relative strength (momentum) and is composed of at least 30 securities from the NASDAQ US Benchmark Index. Many of PTH holdings are involved in developing COVID vaccines and much more.

Gray Cardiff, Sound Advice, soundadvice-newsletter.com, 800-825-7007, March 31, 2021